Patent ID: 6113939
Filing Date: 2000-09-05
Classification: A61F,A61K,A61M

Abstract:
A composition for treating priapism and suitable for administration via the urethra, comprising, in unit dosage form, a therapeutic amount of a vasoconstrictor selected from the group consisting of epinephrine, phenylethylamine, norepinephrine, dopamine, metaraminol, phenylephrine, methoxamine, ephedrine, phenylpropanolamine, mephentermine, propylhexedrine, butoxamine, dichloroisoproterenol, propranolol, alprenolol, bunolol, nadolol, oxprenolol, penbutolol, pindolol, sotalol, timolol, metopropolol, atenolol, acebutolol, bevantolol, pafenolol, tolamolol, and combinations thereof, dispersed in a dispersant effective to facilitate delivery of the active agent through the urethra, wherein the composition is in the form of a urethral suppository, and further wherein the therapeutic amount of the vasoconstrictor is effective to treat an individual suffering from priapism when the composition is administered urethrally.